INDEMNITY AGREEMENTIndemnification Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of March 1, 2021, by and between Orion Acquisition Corp., a Delaware corporation (the “Company”), and (“Indemnitee”).
36,000,000 Units Orion Acquisition Corp. UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
ORION ACQUISITION CORP.Securities Subscription Agreement • February 12th, 2021 • Orion Acquisition Corp. • Blank checks • Delaware
We are pleased to accept the offer Orion Healthcare Acquisition Partners, LLC (the “Subscriber” or “you”) has made to purchase 8,625,000 shares of Class B common stock (the “Shares”), $0.0001 par value per share (the “Class B Common Stock” together with all other classes of Company (as defined below) common stock, the “Common Stock”), up to 1,125,000 Shares of which are subject to complete or partial forfeiture by you if the underwriters of the initial public offering (“IPO”) of Orion Acquisition Corp., a Delaware corporation (the “Company”), do not fully exercise their over-allotment option (the “Over-allotment Option”). The terms (this “Agreement”) on which the Company is willing to sell the Shares to the Subscriber, and the Company and the Subscriber’s agreements regarding such Shares, are as follows:
Orion Acquisition Corp. New York, NY 10153Underwriting Agreement • May 31st, 2022 • Orion Acquisition Corp. • Blank checks • New York
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Orion Acquisition Corp., a Delaware corporation (the “Company”) and Credit Suisse Securities (USA) LLC, as underwriter (the “Underwriter”), relating to an underwritten initial public offering (the “Public Offering”) of 41,400,000 of the Company’s units (including 5,400,000 units that may be purchased pursuant to the Underwriter’s option to purchase additional units, the “Units”), each comprising of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one-quarter of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a registration statement on Form S-1 and a prospectus (the “P
WARRANT AGREEMENT between ORION ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANYWarrant Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
THIS WARRANT AGREEMENT (this “Agreement”), dated as of March 1, 2021, is by and between Orion Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • February 12th, 2021 • Orion Acquisition Corp. • Blank checks • New York
THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of , 2021, is entered into by and among Orion Acquisition Corp., a Delaware corporation (the “Company”), and Orion Healthcare Acquisition Partners, LLC, a Delaware limited liability company (the “Purchaser”).
REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENTRegistration and Stockholder Rights Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of March 1, 2021, is made and entered into by and among Orion Acquisition Corp., a Delaware corporation (the “Company”), Orion Healthcare Acquisition Partners, LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of March 1, 2021, is entered into by and among Orion Acquisition Corp., a Delaware corporation (the “Company”), and Orion Healthcare Acquisition Partners, LLC, a Delaware limited liability company (the “Purchaser”).
SERVICES AGREEMENTServices Agreement • February 23rd, 2021 • Orion Acquisition Corp. • Blank checks • Delaware
This Services Agreement (this “Agreement”) is dated as of February 12, 2021 (the “Effective Date”) by and between Orion Healthcare Acquisition Partners, LLC, a Delaware limited liability company (“Orion”) and Halle Orion Holdings LLC, a Delaware limited liability company (“Halle”). Orion and Halle are each referred to individually as a “Party,” and collectively the “Parties,” under this Agreement.
ORION ACQUISITION CORP. 767 3rd Avenue, 11th Floor New York, NY 10017Letter Agreement • February 12th, 2021 • Orion Acquisition Corp. • Blank checks • New York
ORION ACQUISITION CORP. 767 3rd Avenue, 11th Floor New York, NY 10017 March 1, 2021Letter Agreement • March 4th, 2021 • Orion Acquisition Corp. • Blank checks • New York
This letter agreement will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration Statement”) for the initial public offering (the “IPO”) of the securities of Orion Acquisition Corp. (the “Company”) and continuing until the earlier of (i) the consummation by the Company of an initial business combination and (ii) the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):
